Publicador de continguts

Resistència antimicrobiana

BL-DetecTool

Optimisation and validation of a rapid, simple test for detecting bacteria resistant to beta-lactam antibiotics

Durada
01/01/2018 - 31/12/2018
Coordinador
Centre aux Energies Atomiques (CEA), France
Finançadors
EIT Health (Innovation by Ideas)

The increasing rates of infections caused by broad-spectrum β-lactamases (ESBLs and carbapenemases)-producing  Enterobacteriaceae is a major public health concern.

To fight efficiently against the emergence and the spread of these multidrug (sometimes even pandrug) resistant bacteria, rapid detection and characterization is a prerequisite to implement proper hygiene and infection control measures, as well as a more adequate empirical treatment. Several methods already exist to detect antimicrobial resistance but these techniques require isolated bacteria and procedures with non-compatible delays (≥16 hours).

Thus, sensitive, rapid, low cost and user-friendly tests need to be implemented in clinical microbiology laboratories. Due to its characteristics the lateral flow immunoassay (LFIA) matches perfectly with these specifications.

Project objetives

The aim of this project is to validate a diagnostic tool using the LFIA technology for the detection of broad spectrum β-lactamases (CTXM) and  carbapenemases (OXA; NDM; KPC, VIM, IMP) directy from biological samples.

We will develop a test consisting of a nitrocellulose strip, which allows the immunological detection, enclosed in a plastic device, which carries out sample treatment. The devices, produced by 3D printing, will be optimized and validated with real clinical samples.

The operational procedures will be improved to fit with clinical habits and analytical specifications (specificity, reproducibility and sensitivity) and a cost-effectiveness analysis will be carried out.

At the end of this project a business concept will be established and training tools for
end-users will be available to accelerate the industrial transfer of this technology and
its implementation in care facilities.

Total funding

500,000 €

Our Team

ISGlobal staff

Altres projectes

Veure projectes passats

COMBACTE

Combatent la Resistència Bacteriana a Europa

GAMA

Development of Novel Gastrointestinal Biomarkers for Use in HIV Incidence Determination in a Sub-Saharan African Setting

COMBACTE-CARE

Combatting Bacterial Resistance in Europe - Carbapenem Resistance

MAMAH

Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women

INTE-AFRICA

Integrating and decentralizing diabetes and hypertension services in Africa

ICARIA

Improving Care through Azithromycin Research for Infants in Africa

PreFIT

Predicting the Future: Incipient Tuberculosis

ANTICOV

Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19

Stool4TB

Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV

TB-RECONNECT

Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status

SToolNIH

Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring

END-VOC

ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)

TwinAir

Digital Twins Enabled Indoor Air Quality Management for Healthy Living

ENDÈMIC

Community knowledge generation through scientific culture, urban ecology and art

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

Hepatitis C Free Baleares

Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.

FLAVOBAC

Nuevas moléculas de oro coordinadas con flavonoides contra bacterias patógenas multirresistentes prioritarias